Rapid News Brief

CVS Health said Nov. 4 that it plans to separate into two publicly traded companies in the first half of 2028, placing its retail pharmacies apart from the Aetna insurance and CVS Caremark pharmacy-benefit businesses.

The proposed structure follows a strategic review by the board. CVS said it will continue operating in its current form until the separation is completed, according to its announcement.

What would move into each company

CVS Pharmacy would include approximately 9,000 retail pharmacies, mail pharmacy, MinuteClinic’s in-person and virtual services, and the Health100 technology services business.

The other company, referred to for now as CVS Health, would include Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health.

That would leave insurance, pharmacy-benefit management, specialty pharmacy and several care-delivery businesses together. The proposal separates the retail pharmacy operation; it does not divide every part of the group’s health care supply chain into a standalone company.

Reuters described the planned breakup as an unwinding of a conglomerate built through years of acquisitions.

CVS said independent leadership teams and capital structures would allow each business to pursue more focused priorities. It also said a separate CVS Pharmacy would seek a wider range of partnerships with insurers, pharmacy-benefit managers and manufacturers. Those are management’s stated goals for the structure.

Leadership and remaining conditions

David Joyner, CVS Health’s current chair and CEO, would hold those positions at the health care services company. Prem Shah, currently group president, would become CEO of CVS Pharmacy. Additional executives and board members will be named later, CVS said.

CVS Health shareholders would own shares in both companies after completion. The transaction remains subject to final board approval, effectiveness of a Form 10 registration statement with the Securities and Exchange Commission, and customary confirmation of its intended tax treatment.

CVS cautioned that the separation may not occur on the terms or timetable outlined. The company said customers would continue receiving medicines, care, benefits and services without interruption while it carries out the separation process.